A Phase Ⅰ / Ⅱ study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy .Albinterferon alfa-2b,a novel fusion protein of human alb ......